About Index Trending news
Analyze
Top 50 Pricing
THERAVECTYS

THERAVECTYS

Work at THERAVECTYS? Add yourself to this profile

THERAVECTYS

THERAVECTYS develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series D)
$18,913,020
Venture capital (Series C)
$9,409,092
Guy PAILLAUD, John PIETERS, Philippe ODDO, +1
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when THERAVECTYS makes some noise.